1. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9 (September 2019) Authors: Ratjen, Felix; Davis, Stephanie D; Stanojevic, Sanja; Kronmal, Richard A; Hinckley Stukovsky, Karen D; Jorgensen, Neal; Rosenfeld, Margaret; Kerby, Gwen; Kopecky, Carol; Anthony, Meg; Mogayzel, Peter; Walker, Doug; Zeglin, Britany; Hoover, Wynton; Hathorne, Heather; Slaten, Katie; Dorkin, Henry (... Journal: Lancet Issue: Volume 7:Issue 9(2019) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Issue 4 (April 2023) Authors: Mayer-Hamblett, Nicole; Ratjen, Felix; Russell, Renee; Donaldson, Scott H; Riekert, Kristin A; Sawicki, Gregory S; Odem-Davis, Katherine; Young, Julia K; Rosenbluth, Daniel; Taylor-Cousar, Jennifer L; Goss, Christopher H; Retsch-Bogart, George; Clancy, John Paul; Genatossio, Alan; O'Sullivan, Bri... Journal: Lancet Issue: Volume 11:Issue 4(2023) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗